| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹1.15 -11.53% | 25,5756.45% |
| 00% | ₹126.7 0% | 820 | ₹2.2 0% | 1,24,00040.35% |
| - | - | 840 | ₹3.45 -13.75% | 30,2255.40% |
| 00% | ₹124 0% | 850 | ₹4.65 5.68% | 51,15088.57% |
| - | - | 860 | ₹5.9 1.72% | 37,97516.66% |
| - | - | 870 | ₹7.8 6.84% | 29,4500% |
| 7750% | ₹76.15 0% | 880 | ₹9.95 4.18% | 4,58,0251.19% |
| 6,2000% | ₹68.3 0% | 890 | ₹12.05 0.83% | 24,025-3.12% |
| 52,70019.29% | ₹39.5 -12.51% | 900 | ₹15.55 3.32% | 2,85,975-3.14% |
| 9,300100% | ₹33.95 -13.83% | 910 | ₹19 -2.31% | 54,250133.33% |
| 1,32,525106.02% | ₹27.7 -15.03% | 920 | ₹24.05 5.48% | 4,80,5009.73% |
| 2,18,55028.76% | ₹22.25 -19.23% | 930 | ₹29.25 4.27% | 1,04,625-29.31% |
| 2,02,27574% | ₹18.9 -18.35% | 940 | ₹35.1 4.3% | 1,05,400-13.92% |
| 3,49,52511.08% | ₹15.6 -19.79% | 950 | ₹41.65 5.17% | 1,64,300-10.54% |
| 2,35,6003.75% | ₹12.75 -21.05% | 960 | ₹48.45 4.3% | 1,35,625-8.85% |
| 1,54,22548.50% | ₹10.55 -21.26% | 970 | ₹53.8 0% | 99,9750% |
| 1,51,125-4.41% | ₹8.5 -24.44% | 980 | ₹62.55 0% | 23,2500% |
| 87,57517.70% | ₹7.2 -23.8% | 990 | ₹49.85 0% | 7750% |
| 5,71,1754.83% | ₹5.8 -26.58% | 1,000 | ₹76.5 0% | 36,4250% |
| 32,5502.43% | ₹4.9 -26.86% | 1,010 | ₹64.45 0% | 1,5500% |
| 1,40,27517.53% | ₹4.15 -25.89% | 1,020 | - | - |
| 55,02597.22% | ₹3.2 -31.18% | 1,030 | - | - |
| 9,09,850-2.89% | ₹2.95 -29.76% | 1,040 | - | - |
| 98,42538.04% | ₹2.25 -38.35% | 1,050 | ₹113.55 0% | 3,1000% |
| 58,90016.92% | ₹2.05 -29.31% | 1,060 | ₹122.95 0% | 6,2000% |
| 65,10082.60% | ₹1.45 -34.09% | 1,080 | - | - |
| 47,275-3.17% | ₹1.05 -19.23% | 1,100 | - | - |
| 22,4750% | ₹1.2 0% | 1,120 | ₹182.6 0% | 8,5250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.